Factors influencing perceptions of breast cancer genetic counseling among women in an urban health care system.
The study assessed perceptions of breast cancer genetic counseling. Focus groups were conducted with twenty women (ages < = 50 years) in a Midwestern, urban health system identified as at above average risk of developing hereditary breast cancer and referred for breast cancer genetic counseling following mammography. All participants associated the words "breast cancer" with fear. African American women who received breast cancer genetic counseling may have channeled their fear into increased vigilance related to breast health. African American women who did not receive breast cancer genetic counseling were most knowledgeable about it. In contrast, Caucasian women who did not receive it reported uncertainty about the role of genetic counseling and testing in assessing breast cancer risk, mistrust in medical professionals, and lack of trust in the accuracy of genetic tests. The results could be used to help develop interventions to improve informed decision-making regarding breast cancer genetic counseling.
Ford
Marvella E
ME
Department of Biostatistics, Bioinformatics, and Epidemiology, Hollings Cancer Center, Medical University of South Carolina, 135 Cannon Street, Suite 303, P.O. Box 250835, Charleston, SC 29425, USA. fordmar@musc.edu
Alford
Sharon Hensley
SH
Britton
Diandra
D
McClary
Beth
B
Gordon
Howard S
HS
D000328:Adult; D001007:Anxiety; D044383:Black People; D001943:Breast Neoplasms / Q000453:epidemiology / Q000235:genetics* / Q000401:mortality / Q000523:psychology*; D005239:Fear; D005260:Female; D005817:Genetic Counseling; D006801:Humans; D008327:Mammography; D008875:Middle Aged; D010353:Patient Education as Topic; D010465:Perception; D011795:Surveys and Questionnaires; D014481:United States / Q000453:epidemiology; D014505:Urban Population; D014930:Women; D001741:Black or African American
Breast Cancer Res Treat. 2005 Oct;93(3):247-53
16228617
Arch Fam Med. 1999 Nov-Dec;8(6):521-8
10575392
Ethn Dis. 2005 Spring;15(2 Suppl 2):S5-9
15822829
J Clin Oncol. 2006 Mar 20;24(9):1357-62
16549830
Urology. 2000 May;55(5):716-20
10792087
J Clin Oncol. 2005 Nov 1;23(31):7967-73
16258097
J Natl Med Assoc. 2000 Mar;92 (3):136-42
10745644
J Nurs Care Qual. 1996 Apr;10(3):28-33
8634468
Prev Med. 1994 Mar;23(2):142-51
8047519
J Fam Pract. 1997 Feb;44(2):169-76
9040520
J Adv Nurs. 1990 Nov;15(11):1281-8
2269750
Cancer. 2005 Dec 1;104(11):2508-16
16222692
J Clin Oncol. 2005 Nov 1;23(31):7836-41
16258086
Health Educ Q. 1993 Fall;20(3):421-9
8307764
Soc Sci Med. 1993 Dec;37(12):1509-20
8303335
Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 2):361-7
10207641
Cancer. 2000 Mar 1;88(5 Suppl):1256-64
10705364
Genet Med. 2005 Apr;7(4):230-8
15834240
J Am Diet Assoc. 2000 Sep;100(9):1023-8
11019349
Clin Genet. 2003 Aug;64(2):131-6
12859408
Cancer Invest. 2005;23(4):285-95
16100940
J Health Soc Behav. 1977 Dec;18(4):348-66
617639
Health Educ Q. 1984 Spring;11(1):1-47
6392204
Genet Med. 2006 Sep;8(9):576-82
16980814
Cancer. 1999 Jul 1;86(1):88-104
10391568
Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 2):369-75
10207642
Oncol Nurs Forum. 1995 Oct;22(9):1355-9
8539176
Ann Behav Med. 2006 Dec;32(3):179-87
17107290
Patient Educ Couns. 2003 Oct;51(2):107-14
14572939
JAMA. 2005 Oct 19;294(15):1925-33
16234499
Nurs Stand. 1998 Feb 4-10;12(20):34-6
9512572
Chest. 1994 Oct;106(4 Suppl):248S-259S
7924552
Am J Public Health. 1994 Jan;84(1):101-3
8279592
J Natl Cancer Inst. 2005 Oct 5;97(19):1407-27
16204691
Res Nurs Health. 1994 Jun;17(3):195-206
8184131
Public Health Rep. 1978 May-Jun;93(3):268-77
652949
JAMA. 2005 Apr 13;293(14):1729-36
15827311
Health Promot Pract. 2005 Oct;6(4):394-404
16210681
J Adv Nurs. 1998 Aug;28(2):345-52
9725732
J Clin Oncol. 2006 Mar 20;24(9):1342-9
16549828
J Genet Couns. 2006 Aug;15(4):293-305
16865561